Comparison of β-adrenergic and glucocorticoid signaling on clock gene and osteoblast-related gene expressions in human osteoblast

Chronobiology International

Volumn 29, Issue 1, 2012, Pages 66-74

  Komoto, Shintaro ^a   Kondo, Hisataka ^a   Fukuta, Osamu ^a   Togari, Akifumi ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Adrenergic receptor agonist; Circadian rhythm; Clock gene; Glucocorticoids; Osteoblasts

Indexed keywords

ARNTL PROTEIN, HUMAN; BETA ADRENERGIC RECEPTOR; CIRCADIAN RHYTHM SIGNALING PROTEIN; CLOCK PROTEIN, HUMAN; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; ISOPRENALINE; PER1 PROTEIN, HUMAN; PER2 PROTEIN, HUMAN; PER3 PROTEIN, HUMAN; PRIMER DNA; TRANSCRIPTION FACTOR ARNTL; TRANSCRIPTION FACTOR CLOCK;

ARTICLE; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CIRCADIAN RHYTHM; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; OSCILLOMETRY; OSTEOBLAST; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUPRACHIASMATIC NUCLEUS; TIME;

ARNTL TRANSCRIPTION FACTORS; CELL LINE; CIRCADIAN RHYTHM; CLOCK PROTEINS; DEXAMETHASONE; DNA PRIMERS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; ISOPROTERENOL; OSCILLOMETRY; OSTEOBLASTS; PERIOD CIRCADIAN PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; SUPRACHIASMATIC NUCLEUS; TIME FACTORS;

EID: 84855445150     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420528.2011.636496     Document Type: Article

References (56)

1. Balsalobre A, Damiola F, Schibler U. (1998). A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell. 93:929-937. (Pubitemid 28280787)
2. Blumsohn A, Herrington K, Hannon RA, Shao P, Eyre DR, Eastell R. (1994). The effect of calcium supplementation on the circadian rhythm of bone resorption. J. Clin. Endocrinol. Metab. 79:730-735. (Pubitemid 24286393)
3. Bonnet N, Benhamou CL, Brunet-Imbault B, Arlettaz A, Horcajada MN, Richard O, Vico L, Collomp K, Courteix D. (2005a). Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats. Bone. 37:622-633. (Pubitemid 41476384)
4. Bonnet N, Brunet-Imbault B, Arlettaz A, Horcajada MN, Collomp K, Benhamou CL, Courteix D. (2005b). Alteration of trabecular bone under chronic beta2 agonists treatment. Med. Sci. Sports Exerc. 37:1493-1501. (Pubitemid 41368492)
5. Bonnet N, Pierroz DD, Ferrari SL. (2008). Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis. J. Musculoskelet. Neuronal Interact. 8:94-104.
6. Burioka N, Takata M, Okano Y, Ohdo S, Fukuoka Y, Miyata M, Takane H, Endo M, Suyama H, Shimizu E. (2005). Dexamethasone influences human clock gene expression in bronchial epithelium and peripheral blood mononuclear cells in vitro. Chronobiol. Int. 22:585-590. (Pubitemid 41140879)
7. Chung S, Son GH, Kim K. (2011). Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications. Biochim. Biophys. Acta. 1812:581-591.
8. Duguay D, Cermakian N. (2009). The crosstalk between physiology and circadian clock proteins. Chronobiol. Int. 26:1479-1513.
9. Dykman TR, Gluck OS, MurphyWA, Hahn TJ, Hahn BH. (1985). Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum. 28:361-368. (Pubitemid 15075486)
10. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G. (2005). Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 434:514-520. (Pubitemid 40477060)
11. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. (1990). Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol. Rev. 70:963-985. (Pubitemid 20364820)
12. Fu L, Lee CC. (2003). The circadian clock: pacemaker and tumour suppressor. Nat. Rev. Cancer. 3:350-361. (Pubitemid 37328855)
13. Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. (2005). The molecular clock mediates leptin-regulated bone formation. Cell. 122:803-815. (Pubitemid 41242643)
14. Fu L, Patel MS, Karsenty G. (2006). The circadian modulation of leptincontrolled bone formation. Prog. Brain Res. 153:177-188. (Pubitemid 44164301)
15. Fujioka A, Takashima N, Shigeyoshi Y. (2006). Circadian rhythm generation in a glioma cell line. Biochem. Biophys. Res. Commun. 346:169-174. (Pubitemid 43884735)
16. Greenspan SL, Dresner-Pollak R, Parker RA, London D, Ferguson L. (1997). Diurnal variation of bone mineral turnover in elderly men and women. Calcif. Tissue Int. 60:419-423. (Pubitemid 27183892)
17. Herzog ED. (2007). Neurons and networks in daily rhythms. Nat. Rev. Neurosci. 8:790-802. (Pubitemid 47462117)
18. Hirota T, Okano T, Kokame K, Shirotani-Ikejima H, Miyata T, Fukada Y. (2002). Glucose down-regulates Per1 and Per2 mRNA levels and induces circadian gene expression in cultured Rat-1 fibroblasts. J. Biol. Chem. 277:44244-44251. (Pubitemid 36157857)
19. Huang TS, Grodeland G, Sleire L, Wang MY, Kvalheim G, Laerum OD. (2009). Induction of circadian rhythm in cultured human mesenchymal stem cells by serum shock and cAMP analogs in vitro. Chronobiol. Int. 26:242-257.
20. Ihara H, Hirukawa K, Goto S, Togari A. (2005). ATP-stimulated interleukin-6 synthesis through P2Y receptors on human osteoblasts. Biochem. Biophys. Res. Commun. 326:329-334. (Pubitemid 39593550)
21. Inouye ST, Kawamura H. (1979). Persistence of circadian rhythmicity in a mammalian hypothalamic "island" containing the suprachiasmatic nucleus. Proc. Natl. Acad. Sci. U. S. A. 76:5962-5966. (Pubitemid 10216696)
22. Ishida A, Mutoh T, Ueyama T, Bando H, Masubuchi S, Nakahara D, Tsujimoto G, Okamura H. (2005). Light activates the adrenal gland: timing of gene expression and glucocorticoid release. Cell Metab. 2:297-307.
23. Kellenberger S, Muller K, Richener H, Bilbe G. (1998). Formoterol and isoproterenol induce c-fos gene expression in osteoblast-like cells by activating beta2-adrenergic receptors. Bone. 22:471-478. (Pubitemid 28226860)
24. Kodama D, Togari A. (2010). Modulation of potassium channels via the alpha(1B)-adrenergic receptor in human osteoblasts. Neurosci. Lett. 485:102-106.
25. Kondo A, Togari A. (2003). In vivo stimulation of sympathetic nervous system modulates osteoblastic activity in mouse calvaria. Am. J. Physiol. Endocrinol.Metab. 285:E661-E667. (Pubitemid 37010847)
26. Kondo A, Togari A. (2004). Activation of osteoblastic functions by a mediator of pain, bradykinin. Biochem. Pharmacol. 68:1423-1431. (Pubitemid 39179400)
27. Kondo H, Togari A. (2011). Continuous treatment with a low-dose beta-agonist reduces bone mass by increasing bone resorption without suppressing bone formation. Calcif. Tissue Int. 88:23-32.
28. Kondo H, Nifuji A, Takeda S, Ezura Y, Rittling SR, Denhardt DT, Nakashima K, Karsenty G, Noda M. (2005). Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. J. Biol. Chem. 280:30192-30200. (Pubitemid 41216198)
29. Krieger DT, Allen W, Rizzo F, Krieger HP. (1971). Characterization of the normal temporal pattern of plasma corticosteroid levels. J. Clin. Endocrinol. Metab. 32:266-284.
30. Manolagas SC, Weinstein RS. (1999). New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J. Bone Miner. Res. 14:1061-1066. (Pubitemid 29314048)
31. Matsuda T, Kondo A, Tsunashima Y, Togari A. (2010). Inhibitory effect of vitamin K(2) on interleukin-1beta-stimulated proliferation of human osteoblasts. Biol. Pharm. Bull. 33:804-808.
32. Mendez-Ferrer S, Lucas D, Battista M, Frenette PS. (2008). Haematopoietic stem cell release is regulated by circadian oscillations. Nature. 452:442-447. (Pubitemid 351450836)
33. Moore RE, Smith CK2nd, Bailey CS, Voelkel EF, Tashjian AH Jr. (1993). Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture. Bone Miner. 23:301-315.
34. Obata K, Furuno T, Nakanishi M, Togari A. (2007). Direct neurite-osteoblastic cell communication, as demonstrated by use of an in vitro co-culture system. FEBS Lett. 581:5917-5922. (Pubitemid 50012298)
35. Ochiai E, Kitagawa H, Takada I, Fujiyama S, Sawatsubashi S, Kim MS, Mezaki Y, Tsushima Y, Takagi K, Azuma Y, Takeyama K, Yamaoka K, Kato S, Kamimura T. (2010). CDP/cut is an osteoblastic coactivator of the vitamin D receptor (VDR). J. Bone Miner. Res. 25:1157-1166.
36. Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911-1929.
37. Reddy AB, Maywood ES, Karp NA, King VM, Inoue Y, Gonzalez FJ, Lilley KS, Kyriacou CP, Hastings MH. (2007). Glucocorticoid signaling synchronizes the liver circadian transcriptome. Hepatology. 45:1478-1488. (Pubitemid 46918332)
38. Reppert SM, Weaver DR. (2002). Coordination of circadian timing in mammals. Nature. 418:935-941. (Pubitemid 34976023)
39. Schibler U, Sassone-Corsi P. (2002). A web of circadian pacemakers. Cell. 111:919-922. (Pubitemid 36044683)
40. Schlemmer A, Hassager C, Pedersen BJ, Christiansen C. (1994). Posture, age, menopause, and osteopenia do not influence the circadian variation in the urinary excretion of pyridinium crosslinks. J. Bone Miner. Res. 9:1883-1888. (Pubitemid 24363144)
41. Schlemmer A, Hassager C, Alexandersen P, Fledelius C, Pedersen BJ, Kristensen IO, Christiansen C. (1997). Circadian variation in bone resorption is not related to serum cortisol. Bone. 21:83-88. (Pubitemid 27341743)
42. Shao P, Ohtsuka-Isoya M, Shinoda H. (2003). Circadian rhythms in serum bone markers and their relation to the effect of etidronate in rats. Chronobiol. Int. 20:325-336. (Pubitemid 36505403)
43. Sherman BE, Chole RA. (2001). Effect of chemical sympathectomy with 6-hydroxydopamine on osteoclast activity in the gerbilline middle ear bulla. Otol. Neurotol. 22:237-241. (Pubitemid 32233482)
44. Silver R, LeSauter J, Tresco PA, Lehman MN. (1996). A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms. Nature 382:810-813. (Pubitemid 26299564)
45. So AY, Bernal TU, PillsburyML, Yamamoto KR, Feldman BJ. (2009). Glucocorticoid regulation of the circadian clock modulates glucose homeostasis. Proc. Natl. Acad. Sci. U. S. A. 106:17582-17587.
46. Suzuki S, Toyabe S, Moroda T, Tada T, Tsukahara A, Iiai T, Minagawa M, Maruyama S, Hatakeyama K, Endoh K, Abo T. (1997). Circadian rhythm of leucocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system. Clin. Exp. Immunol. 110:500-508. (Pubitemid 27525285)
47. Takeda S. (2004). Leptin and beta-blockers in bone metabolism. Clin. Calcium 14:241-247.
48. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G. (2002). Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305-317. (Pubitemid 35345151)
49. Togari A. (2002). Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc. Res. Tech. 58:77-84. (Pubitemid 34778973)
50. Togari A, Arai M. (2008). Pharmacological topics of bone metabolism: the physiological function of the sympathetic nervous system in modulating bone resorption. J. Pharmacol. Sci. 106:542-546. (Pubitemid 351556230)
51. Togari A, Arai M, Mizutani S, Mizutani S, Koshihara Y, Nagatsu T. (1997). Expression of mRNAs for neuropeptide receptors and beta-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells. Neurosci. Lett. 233:125-128. (Pubitemid 27418180)
52. Togari A, Mogi M, Arai M, Yamamoto S, Koshihara Y. (2000). Expression of mRNA for axon guidance molecules, such as semaphorin- III, netrins and neurotrophins, in human osteoblasts and osteoclasts. Brain Res. 878:204-209.
53. Togari A, Arai M, Kondo A. (2005). The role of the sympathetic nervous system in controlling bone metabolism. Expert Opin. Ther. Targets 9:931-940. (Pubitemid 41488831)
54. Uemura T, Ohta Y, Nakao Y, Manaka T, Nakamura H, Takaoka K. (2010). Epinephrine accelerates osteoblastic differentiation by enhancing bone morphogenetic protein signaling through a cAMP/protein kinase A signaling pathway. Bone 47:756-765.
55. Wu X, Yu G, Parks H, Hebert T, Goh BC, Dietrich MA, Pelled G, Izadpanah R, Gazit D, Bunnell BA, Gimble JM. (2008). Circadian mechanisms in murine and human bone marrow mesenchymal stem cells following dexamethasone exposure. Bone 42:861-870.
56. Zvonic S, PtitsynAA, Kilroy G,WuX,ConradSA, ScottLK,GuilakF, Pelled G, Gazit D, Gimble JM. (2007). Circadian oscillation of gene expression in murine calvarial bone. J. Bone Miner. Res. 22:357-365. (Pubitemid 46797118)